Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

48941 - 48950 of 60077 results found

Evaluation of off-label rapamycin use to promote healthspan in 333 adults

Date
Tuesday, May 16, 2023 - 4:00 AM
Description
Rapamycin (sirolimus) is an FDA-approved drug with immune-modulating and growth-inhibitory properties. Preclinical studies have shown that rapamycin extends lifespan and healthspan metrics in yeast, invertebrates, and rodents. Several physicians are